V Chemostart Edition Winners
Aromics – MiMark Diagnostics – AntalGenics
ChemoStart is a global programme which provides support for startups and companies
designing innovative projects in the field of health and medical care.
NEW MEDICINES
WEARABLES
ARTIFICIAL INTELLIGENCE
DIAGNOSTICS METHODS
PRECISION MEDICINE
NEW APPLIED THECNOLOGIES
ChemoStart offers the winning startups a support programme which is tailored to their own specific needs. Each project is allocated a designated project manager to provide specific support on commercial processes, intellectual property, marketing and manufacturing, among other areas.
together, we will define the roadmap for your project to indetify the mentors who are best placed to meet your needs.
We´ll provide you with space at our offices so we can work side-by-side on your projet.
We´ll share our contact network with you to help grow your business and roll out pilot test.
We analyse startups and invest depending on the stage they are at (seed, early stage, series A)
Would you like a meeting with us? We provide training sessions and visits to our facilities so you can get a first-hand insight into how we work. Get in touch and get the full ChemoStart experience!
PITCH SESSION INVESTMENT SESSIONCOME AND MEET USINSUD PHARMA TOUR
Send us an email, we´ll be delighted to hear from you.
Marisa Abad
Manager at Beckman Coulter
Juan Alcántara
CEO at Nuubo
Felipe Blanco
Senior Advisor at Triton Partners
Juan Cruz Cigudosa
Science and Innovation Director & Founding Partner at NIMGenetics
Jaime Delgado Rodríguez
Consultant at Nowture
Adrià Escolá
Project Innovation Manager at Vall d’Hebron Research
Jordi Ferrer
Investment Director at Ship2B Ventures
Mario Grande Abascal
Managing Partner at Nowture
Antonio Herce
Investment Associate at Life Sciences at Inveready
Elena Hernando
Group Leader at Universidad Politécnica Madrid
Robert Jenkins
CEO at Geroa Diagnostics & at Invezyme Research
Carlos R. Larrea
Business Development Manager at Innova-tsn
Maite Malet
Investment Analyst at Asabys Partners
Raúl Martín-Ruiz
Partner at Ysios Capital
Guillem Masferrer
Investment Associate at Asabys Partners
Santiago Peinado
Laboratory Consultant
María Poveda
Investment Associate at Life Sciences at Inveready
Jaime Rivas
Associate Director Government Affairs at Insud Pharma
Enrique Samper
CEO & Founding Partner at NIMGenetics
Borja Smith
Partner at Bio-Innova
María Sola Gil
Managing Director at Neurofix Pharma
Michael Tadros
Project Manager at Fundación Botín
Beatriz Volckaert
Investment Analyst at Ship2B Ventures